Mutations that impair kinase function of Eph receptors, such as EphB2, EphA3, EphA5, are frequently found in cancer, suggesting a tumor suppressor role for Eph receptor forward signaling [69–71] (Table 2). This evidence concerns the gene EPHA3 and neoplasm.